Similar articles for PMID: 22065733

Year	Number of Results
1995	1
1997	1
1998	1
1999	3
2001	2
2003	1
2004	2
2005	2
2007	1
2008	2
2010	2
2011	10
2012	8
2013	7
2014	7
2015	5
2016	6
2017	4
2018	13
2019	7
2020	10
2023	1
2024	0

1

MicroRNA and vascular remodelling in acute vascular injury and pulmonary vascular remodelling.

McDonald RA, Hata A, MacLean MR, Morrell NW, Baker AH. McDonald RA, et al. Cardiovasc Res. 2012 Mar 15;93(4):594-604. doi: 10.1093/cvr/cvr299. Epub 2011 Nov 7. Cardiovasc Res. 2012. PMID: 22065733 Free PMC article. Review.

2

Dynamic and diverse changes in the functional properties of vascular smooth muscle cells in pulmonary hypertension.

Stenmark KR, Frid MG, Graham BB, Tuder RM. Stenmark KR, et al. Cardiovasc Res. 2018 Mar 15;114(4):551-564. doi: 10.1093/cvr/cvy004. Cardiovasc Res. 2018. PMID: 29385432 Free PMC article. Review.

3

Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation.

Davis-Dusenbery BN, Wu C, Hata A. Davis-Dusenbery BN, et al. Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2370-7. doi: 10.1161/ATVBAHA.111.226670. Arterioscler Thromb Vasc Biol. 2011. PMID: 22011749 Free PMC article. Review.

4

Role of noncoding RNA in vascular remodelling.

Deng L, Bradshaw AC, Baker AH. Deng L, et al. Curr Opin Lipidol. 2016 Oct;27(5):439-48. doi: 10.1097/MOL.0000000000000336. Curr Opin Lipidol. 2016. PMID: 27472407 Review.

5

The multifactorial nature of microRNAs in vascular remodelling.

Welten SM, Goossens EA, Quax PH, Nossent AY. Welten SM, et al. Cardiovasc Res. 2016 May 1;110(1):6-22. doi: 10.1093/cvr/cvw039. Epub 2016 Feb 23. Cardiovasc Res. 2016. PMID: 26912672 Review.

6

Adipolin/CTRP12 protects against pathological vascular remodelling through suppression of smooth muscle cell growth and macrophage inflammatory response.

Ogawa H, Ohashi K, Ito M, Shibata R, Kanemura N, Yuasa D, Kambara T, Matsuo K, Hayakawa S, Hiramatsu-Ito M, Otaka N, Kawanishi H, Yamaguchi S, Enomoto T, Abe T, Kaneko M, Takefuji M, Murohara T, Ouchi N. Ogawa H, et al. Cardiovasc Res. 2020 Jan 1;116(1):237-249. doi: 10.1093/cvr/cvz074. Cardiovasc Res. 2020. PMID: 30874788

7

The role of microRNAs in arterial remodelling.

Nazari-Jahantigh M, Wei Y, Schober A. Nazari-Jahantigh M, et al. Thromb Haemost. 2012 Apr;107(4):611-8. doi: 10.1160/TH11-12-0826. Epub 2012 Feb 28. Thromb Haemost. 2012. PMID: 22371089 Review.

8

Pathobiology of pulmonary artery hypertension: role of long non-coding RNAs.

Zahid KR, Raza U, Chen J, Raj UJ, Gou D. Zahid KR, et al. Cardiovasc Res. 2020 Oct 1;116(12):1937-1947. doi: 10.1093/cvr/cvaa050. Cardiovasc Res. 2020. PMID: 32109276 Review.

9

MicroRNA-26a is a novel regulator of vascular smooth muscle cell function.

Leeper NJ, Raiesdana A, Kojima Y, Chun HJ, Azuma J, Maegdefessel L, Kundu RK, Quertermous T, Tsao PS, Spin JM. Leeper NJ, et al. J Cell Physiol. 2011 Apr;226(4):1035-43. doi: 10.1002/jcp.22422. J Cell Physiol. 2011. PMID: 20857419 Free PMC article.

10

Deficiency of MAPK-activated protein kinase 2 (MK2) prevents adverse remodelling and promotes endothelial healing after arterial injury.

Kapopara PR, von Felden J, Soehnlein O, Wang Y, Napp LC, Sonnenschein K, Wollert KC, Schieffer B, Gaestel M, Bauersachs J, Bavendiek U. Kapopara PR, et al. Thromb Haemost. 2014 Dec;112(6):1264-76. doi: 10.1160/TH14-02-0174. Epub 2014 Aug 14. Thromb Haemost. 2014. PMID: 25120198

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

86 results

Results by year